NIH-funded research Fellowship grant

Understanding how a specific protein affects egg development and fertility.

Official title: Elucidating the mechanism by which Elastin Microfibril interface-located protein 1 (EMILIN1) contributes to folliculogenesis

Funded at Lurie Children's Hospital of Chicago · NIH-10997060 · Data updated 2026-11-12

This study is looking at how a protein called EMILIN1 might help improve egg growth for people with premature ovarian insufficiency (POI), using special materials from cow ovaries to potentially boost fertility options for those having trouble getting pregnant.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 16, 2024
Project endSeptember 15, 2027
Funding year2024
Award (this year)$44,187
NIH project number1F31HD116552-01
Project IDNIH-10997060 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing premature ovarian insufficiency or those seeking to preserve their fertility due to medical conditions or treatments.

Less likely to help

Patients who are not experiencing fertility issues or those who have already achieved successful pregnancies may not benefit from this research.

What this research studies

This research focuses on premature ovarian insufficiency (POI), a condition that leads to infertility due to decreased ovarian function. The study aims to explore the role of a protein called EMILIN1 in the development of ovarian follicles, which are essential for egg maturation. By using advanced biomaterials derived from bovine ovarian tissue, the researchers hope to enhance follicle growth and improve the quality of eggs in laboratory settings. This could lead to better fertility preservation techniques for individuals facing challenges in conceiving.

Why it matters

Potential benefit: If successful, this research could lead to improved fertility preservation methods for individuals with premature ovarian insufficiency.

How similar studies have gone: Previous research has shown promise in using biomaterials for enhancing fertility outcomes, suggesting that this approach could yield significant advancements.

Where this research is happening

  • Lurie Children's Hospital of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Mcdowell, Hannah — Lurie Children's Hospital of Chicago
  • Study coordinator: Mcdowell, Hannah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.